BRITTANY KOLANSKI: Open Payments
NPI 1851740260 · ZANESVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$900 in 54 payments from 14 companies in 2025. Trend: 2023 $692 · 2024 $1,010 · 2025 $900
Food & beverage: $900
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $196 |
| Janssen Pharmaceuticals, Inc | 5 | $102 |
| Otsuka America Pharmaceutical, Inc. | 4 | $99 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $88 |
| E.R. Squibb & Sons, L.L.C. | 3 | $63 |
| Supernus Pharmaceuticals, Inc. | 3 | $58 |
| Collegium Pharmaceutical, Inc. | 3 | $56 |
| Lundbeck LLC | 3 | $52 |
| Neurocrine BioSciences, Inc. | 2 | $42 |
| Janssen Scientific Affairs, LLC | 1 | $39 |
Products named: VRAYLAR, REXULTI, CAPLYTA, SPRAVATO, COBENFY, INVEGA, Qelbree, Jornay PM.
Industry payments across OH — which companies pay providers there.
